Mabion is a European biotechnology company developing drugs of the recombinant protein class, including monoclonal antibodies and vaccines. It is a forerunner in the biotechnology sector in Central Europe. Mabion specializes in manufacturing sterile biotechnology products in a Good Manufacturing Practice (GMP) compliant facility, and the company’s goal is to integrate and commercialize scientific achievements to produce a biological therapeutic substance based on mammalian cell culture.